Regeneron Pharmaceuticals, Inc. (REGN)

750.57 +4.57 (+0.61%) USD  |  NASDAQ  |  Apr 17, 16:00
749.43 -1.14 (-0.15%) After-Hours: 20:00
More

Regeneron Pharmaceuticals SG&A Expense (Quarterly) : 775.00M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for REGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Amgen, Inc. 1.952B
Eli Lilly & Co. 3.132B
Merck & Co., Inc. 2.898B
Pfizer Inc. 4.162B
AbbVie, Inc. 3.895B